Guizhou Xinbang Pharmaceutical Co Ltd
SZSE:002390
Guizhou Xinbang Pharmaceutical Co Ltd
Cash from Investing Activities
Guizhou Xinbang Pharmaceutical Co Ltd
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Guizhou Xinbang Pharmaceutical Co Ltd
SZSE:002390
|
Cash from Investing Activities
-¥85.5m
|
CAGR 3-Years
-114%
|
CAGR 5-Years
12%
|
CAGR 10-Years
9%
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Cash from Investing Activities
-¥5.9B
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Cash from Investing Activities
-¥2.1B
|
CAGR 3-Years
-42%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-31%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Cash from Investing Activities
¥73.3m
|
CAGR 3-Years
-66%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Cash from Investing Activities
¥518.6m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
6%
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Cash from Investing Activities
-¥93m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
See Also
What is Guizhou Xinbang Pharmaceutical Co Ltd's Cash from Investing Activities?
Cash from Investing Activities
-85.5m
CNY
Based on the financial report for Sep 30, 2023, Guizhou Xinbang Pharmaceutical Co Ltd's Cash from Investing Activities amounts to -85.5m CNY.
What is Guizhou Xinbang Pharmaceutical Co Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
9%
Over the last year, the Cash from Investing Activities growth was 59%. The average annual Cash from Investing Activities growth rates for Guizhou Xinbang Pharmaceutical Co Ltd have been -114% over the past three years , 12% over the past five years , and 9% over the past ten years .